This site uses technical cookies, Analytics cookies and third-party cookies for the operation of the site and to improve the user experience.
Founded in 2011 by renowned entrepreneurs with the mission to Eliminate Unnecessary Blindness, salauno is an ophthalmology system that works with innovative medical and engineering processes and the latest technology to help reduce the backlog of eye care services.
Sansure Biotech Inc., now a listed company in China, established in 2008, is an integrated solutions manufacturer and provider with independent innovation of molecular diagnostics and gene technology, has over 10-year experience specialized in diagnostic reagents, nucleic acid diagnostic instruments, complete lab solutions and lab chain services. Sansure solutions for molecular diagnosis are compatible with majority of PCR detection instruments and lab environments based on unique technical platforms “global leading magnetic beads extraction system”, “one of the simplest and fastest one-step DNA/RNA lysis systems”, automated nucleic acid extraction system, POCT devices and real-time PCR instruments. Over 40% of its employees work for R&D and technical service departments, over one hundred of products with global registrations, including infectious diseases, cancer, maternal and child health, blood screening, emerging infectious diseases prevention and control, chronic disease management, etc.
During global COVID-19 pandemic, Sansure solutions, precise, fast, simple, easy-to-use and high-throughput, become the major COVID-19 detection solutions in China and other countries, contributing to the world pandemic prevention and control. The full range integrated solution includes " 2019-nCoV nucleic acid diagnostic kit + 2019-nCoV antigen test + 2019-nCoV POCT rapid test + 2019-nCoV/Flu A /Flu B triple test + 2019-nCoV and Six Respiratory Pathogens Nucleic Acid Diagnostic Kit + 2019-nCoV mutant B117 identification test", which can cover the common mutant types reported.
"Sansure solutions" have been widely used in nearly 160 countries worldwide, such as France, UK, Germany, Russia, the Philippines, Brazil etc., obtained certificates in over 65 countries, include NMPA China, US FDA EUA，ANVISA, TGA Australia, We are one of the companies with the largest number of overseas certificates.
Segmentify is the smartest and most intuitive eCommerce personalisation platform supporting retailers in enhancing their conversion rates, increasing average order values, and offering cross-selling and up-selling by capitalising on personalisation tiered towards individual visitors regardless if they are accessing the site through the web, mobile web, mobile app, onsite search or push notifications.
Segmentify creates an Amazon grade personalised shopping experience across every customer touchpoint in real-time, giving retailers the best advantage over competition.
Powered by machine-learning technology, Segmentify tracks and targets individual website visitors according to their unique online buying habits better than any personalisation platform on the market. Forbes mentioned us as one of the top machine learning companies to watch.
Our SaaS AI is actively being used by 180 Brands, like Puma, Celtic FC, Ebuyer, Sephora, Bauhaus and Intersport from 27 countries, mainly in Europe.
Shift Technology delivers the only AI-native decision automation and optimization solutions built specifically for the global insurance industry. Addressing several critical processes across the insurance policy lifecycle, the Shift Insurance Suite helps insurers achieve faster, more accurate claims and policy resolutions. Shift has analyzed billions of insurance transactions to date. For more information, please visit www.shift-technology.com.
The number of people aged 65 or over is projected to double and reach the 1.5 billion figure in 2050. In 1990, senior people represented 6% of the population. By 2050 they will represent 16%, that is, one in six people will be above 65 years old. This situation will put extra financial pressure on both health and social care systems.
Elderly people want to stay at their homes as long as possible. A technological solution that monitors them at home while respecting their privacy and autonomy would address both the economic and social challenges.
Sofiathinks has developed a product to serve this purpose. Our product is based on non-wearable super sensors and artificial intelligence, which allows us to transparently learn daily habits and warn relatives and/or professional caregivers in case of anomalies or situations that could pose a risk to the person being monitored.